Company: HURA
Filing Date: 2025-12-10
Form Type: 424B5
Source: 0001193125-25-313799
Chunk: 70

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-12-10
Form: 424B5
Chunk 70
---
 set forth in their report appearing elsewhere herein, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing. WHERE YOU CAN FIND MORE INFORMATION We file annual, quarterly and current reports, proxy statements and other information with the SEC. We also filed a registration statement on Form S-3,including exhibits, under the Securities Act with respect to the securities offered by this prospectus. This prospectus is a part of the registration statement, but does not contain all of the information included in the registration statement or the exhibits. The SEC maintains a web site, www.sec.gov, that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC. You may review the registration statement and any other document we file on the SEC’s web site. Our SEC filings are also available to the public on our website, www.tuhurabio.com. The information on our website, however, is not, and should not be deemed to be, a part of this prospectus. We are “incorporating by reference” specified documents that we file with the SEC, which means:

| • |     | incorporated documents are considered part of this prospectus; |

| • |     | we are disclosing important information to you by referring you to those documents; and |

| • |     | information we file with the SEC will automatically update and supersede information contained in this 
 prospectus.                                                                                            |

We incorporate by reference the documents listed below and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (i) after the date of filing of the registration statement of which this prospectus is a part and prior to the effectiveness of such registration statement and (ii) on or after the date of this prospectus until the earlier of the date on which all of the securities registered hereunder have been sold or the registration statement of which this prospectus is a part has been withdrawn:

38

Notwithstanding the foregoing, information furnished under Items 2.02 and 7.01 of any Current Report on Form 8-K,including the related exhibits under Item 9.01, is not incorporated by reference in this prospectus. You may request a copy of any of these filings, at no cost, by request directed to us at the following address or telephone number: TuHURA Biosciences, Inc. 10500 University Center Drive, Suite 110 Tampa, Florida